P-086EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment. (2nd July 2019) - Su, M; Chen, L; Hitre, E; Lee, W; Bai, L; Papai, Z; Kang, S; Dvorkin, M; Lee, M; Ludovic, E; Choi, H; Oh, S; et al.